Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

FDA: Accelerated approval for Genmab and Seagen’s TIVDAK

September 21, 2021 Manufacturing and Production, Research and Development

The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate …
News

Singapore scientists turn discarded fruit peel into antibacterial bandages

September 20, 2021 Research and Development, Sales and Marketing

Scientists at Nanyang Technological University (NTU) in Singapore have created antibacterial organo-hydrogel bandages from discarded durian peel.The process extracts cellulose …
News

Cambodian bat researchers aiming to find COVID-19 origin

September 20, 2021 Research and Development, Sales and Marketing

An eight-member Institut Pasteur du Cambodge (IPC) research team has been collecting samples from bats in an attempt to discover …
News

NICE recommends MSD’s Keytruda for oesophageal cancer patients

September 17, 2021 Medical Communications, Research and Development

NICE has approved the use of pembrolizumab – MSD’s checkpoint inhibitor immunotherapy – in combination with platinum- and fluoropyrimidine-based chemotherapy, …
News

Researchers develop AI algorithm to diagnose deep vein thrombosis

September 16, 2021 Medical Communications, Research and Development

Researchers from the University of Oxford, Imperial College, and the University of Sheffield have developed a machine learning algorithm with …
News

Sanofi complete acquisition of mRNA company Translate Bio

September 15, 2021 Research and Development 2021, 3.2 billion, COVID-19, Sanofi, Translate Bio, acquisition, mrna, vaccines

French pharma giants Sanofi continues its run of acquisitions in 2021 by completing the deal for Translate Bio, a Massachusetts-based …
News

COVID deaths among fully vaccinated rare, ONS data finds

September 15, 2021 Medical Communications, Research and Development

New figures from the Office for National Statistics (ONS) show that fully vaccinated people are far less likely to die …
News

Sajid Javid: Valneva COVID vaccine would not have been approved by MHRA

September 15, 2021 Manufacturing and Production, Medical Communications, Research and Development

On Monday the UK cancelled a deal with French vaccine maker Valneva worth up to €1.4 billion, and Health Secretary …
News

Israeli survey finds 1 in 10 children have long COVID

September 14, 2021 Medical Communications, Research and Development

An Israeli Health Ministry survey has found that one in ten children have lingering COVID-19 symptoms after contracting and recovering …
News

J&J publish promising Ebola vaccine data

September 14, 2021 Research and Development

Johnson & Johnson have released promising data regarding their Ebola vaccine regimen, as it demonstrates antibody immune responses in adults …
News
valneva-05

Valneva COVID-19 vaccine deal pulled by UK government

September 13, 2021 Research and Development, Sales and Marketing Boris Johnson, Scotland, UK government, Vaccine, Valneva, booster, covid19

Boris Johnson and the UK government have terminated its deal with specialist vaccine company Valneva after it was alleged the …
News
nhs_old_hospital_1

NHS lung cancer patients to receive Amgen’s tumour-stopping drug

September 10, 2021 Medical Communications, Research and Development

NHS patients will be the first in Europe to receive a new drug that can prevent lung cancer tumour growth, …
News

FDA grants Fast Track Designation for Vor Biopharma’s AML drug

September 10, 2021 Medical Communications, Research and Development

Vor Biopharma has announced that the FDA has granted their acute myeloid leukemia (AML) engineered hematopoietic stem cell therapy (eHSC), …
News

Trials of former Theranos CEO Elizabeth Holmes are underway

September 8, 2021 Medical Communications, Research and Development

The highly anticipated trials of Elizabeth Holmes, founder and former CEO of the now-defunct Theranos, have commenced. Prosecutors are to …
News

J&J’s prostate cancer drug recommended by NICE

September 8, 2021 Research and Development

J&J have announced NICE are recommending apalutamide for treating prostate cancer following new draft guidance by the body. This is …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025